Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

22NW, LP 13F Holdings -- Portfolio & Top Positions (2026-03-31)

22NW, LP (CIK 1694297) reported $145.9M across 16 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: FSTR ($29.8M, 20.41%), NKTR ($20.2M, 13.86%), LFCR ($18.9M, 12.93%), NSP ($13.3M, 9.14%), MLYS ($12.0M, 8.25%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1FSTRFOSTER L B CO$29.8M20.41%1.1MTrimmed
2NKTRNEKTAR THERAPEUTICS$20.2M13.86%281,115Trimmed
3LFCRLIFECORE BIOMEDICAL INC$18.9M12.93%1,254Hold
4NSPINSPERITY INC$13.3M9.14%493,000Added
5MLYSMINERALYS THERAPEUTICS INC$12.0M8.25%444,325Added
6SRISTONERIDGE INC$11.9M8.17%2.5MAdded
7FOXFFOX FACTORY HLDG CORP$11.2M7.65%678,165New
8CULPCULP INC$5.1M3.49%1.9MHold
9CMTCORE MOLDING TECHNOLOGIES IN$5.0M3.42%222,738Hold
10RGNXREGENXBIO INC$4.1M2.83%492,759Trimmed
11UFIUNIFI INC$3.0M2.09%852,455Hold
12TISITEAM INC$2.7M1.86%170,187Hold
13RZLTREZOLUTE INC$2.5M1.72%820,653Hold
14FARMFARMER BROS CO$2.5M1.70%2.0MHold
15ELDNELEDON PHARMACEUTICALS INC$2.0M1.34%636,364Hold
16PFXPHENIXFIN CORP$1.7M1.15%43,115Trimmed
17ANEBANEBULO PHARMACEUTICALS INC$00.00%0Exited
18MECMAYVILLE ENGR CO INC$00.00%0Exited
19PMDIPSYCHEMEDICS CORPORATION CMN$00.00%0Exited
20SSKNSTRATA SKIN SCIENCES INC$00.00%0Exited
21MGTXMEIRAGTX HLDGS PLC$00.00%0Exited

Source: SEC Form 13F filings · as of 2026-03-31